Monitor LAB's stock price trajectory over the next 180 days; watch for announcements regarding a reverse stock split or capital raise. A failure to regain compliance by October 19, 2026, could trigger forced delisting to OTC markets, significantly reducing institutional ownership and liquidity.
How the stock moved after the report
BEARISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Apr 27 $0.9000entry
- T+1 · 7mo ago +2.22%α +2.71% · $0.9200
- T+5 · 7mo ago +4.44%α +4.04% · $0.9400
- T+20 · 6mo ago +21.11%α +16.15% · $1.09
- T+60 · 4mo ago −9.07%α −13.84% · $0.8184
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Standard BioTools Inc. (LAB) received a Nasdaq delisting notice for failing to maintain a $1.00 minimum bid price over 30 consecutive days. The company has until October 19, 2026, to regain compliance by closing above $1.00 for 10 consecutive business days. Trading continues uninterrupted during this period.
Key Facts
- Received Nasdaq delisting notice on April 20, 2026, for failing to meet the $1.00 minimum bid price requirement (Nasdaq Listing Rule 5450(a)(1))
- Triggered after 30 consecutive business days with closing bid price below $1.00
- 180-day compliance period granted, expiring October 19, 2026
- May qualify for an additional 180-day extension by transferring to Nasdaq Capital Market and meeting other listing standards
- Potential remedies include a reverse stock split or capital raise
- No immediate trading halt; stock continues to trade on Nasdaq Global Select Market under ticker LAB
Financial Impact
Significant reputational and liquidity risk if delisting occurs; potential 20-30% stock price decline based on historical biotech delisting precedents
Risk Factors
- Failure to regain compliance by October 19, 2026, leading to delisting from Nasdaq
- Negative market perception and potential decline in investor confidence
- Reduced liquidity and institutional ownership if delisted
- Potential need for a dilutive capital raise or value-destroying reverse stock split
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-177290 |
| Document: 0001193125-26-177290-index-headers.html | 0001193125-26-177290 |
| Document: 0001193125-26-177290-index.html | 0001193125-26-177290 |
| Document: 0001193125-26-177290.txt | 0001193125-26-177290 |
Track record
23 reports on LAB
7 of 8 bullish or bearish reports moved the stock their way by T+1. Best: +17.95% at T+20 after the Feb 24, 2026 report. 8 of 8 went positive at some point.
Filters
- Nov 16, 2026today 425 Neutral 4/10 Entry price pending
- Nov 16, 2026today 8-K Neutral 3/10 Entry price pending
- Nov 3, 202613d ago 425 Neutral 3/10 Entry $0.6108 to $0.6160 Now $0.6200 +1.51% ▲ +0.85% −0.80% vs SPY
- Nov 3, 202613d ago 8-K Neutral 4/10 Entry $0.6108 to $0.6160 Now $0.6200 +1.51% ▲ +0.85% −0.80% vs SPY
- Nov 3, 202613d ago Press Release Neutral 3/10 Entry $0.6108 to $0.6160 Now $0.6200 +1.51% ▲ +0.85% −0.80% vs SPY
- Oct 22, 202626d ago EFFECT Neutral 4/10 Entry $0.6400 to $0.6056 Now $0.6200 −3.12% ▼ −5.38% −4.85% vs SPY
- Oct 21, 202626d ago S-4/A Bearish 7/10 Entry $0.6500 to $0.6400 Now $0.6200 +4.62% ▲ +1.54% +0.36% vs SPY
- Oct 9, 20265w ago S-4/A Neutral 6/10 Entry $0.6578 to $0.6589 Now $0.6200 −5.75% ▲ +0.17% +0.18% vs SPY
- Oct 5, 20266w ago 425 Neutral 5/10 Entry $0.7220 to $0.6787 Now $0.6200 −14.13% ▼ −6.00% −5.76% vs SPY
- Oct 5, 20266w ago 8-K Neutral 4/10 Entry $0.7220 to $0.6787 Now $0.6200 −14.13% ▼ −6.00% −5.76% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers